25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Guangdong Taienkang Pharmaceutical Co. Ltd
Buy, Hold or Sell?

Let's analyze Guangdong Taienkang Pharmaceutical Co. Ltd together

I guess you are interested in Guangdong Taienkang Pharmaceutical Co. Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Guangdong Taienkang Pharmaceutical Co. Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Guangdong Taienkang Pharmaceutical Co. Ltd

I send you an email if I find something interesting about Guangdong Taienkang Pharmaceutical Co. Ltd.

1. Quick Overview

1.1. Quick analysis of Guangdong Taienkang Pharmaceutical Co. Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Guangdong Taienkang Pharmaceutical Co. Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.05
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥4.19
Expected worth in 1 year
¥4.09
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
¥0.24
Return On Investment
1.7%

For what price can you sell your share?

Current Price per Share
¥14.24
Expected price per share
¥13.28 - ¥16.84
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Guangdong Taienkang Pharmaceutical Co. Ltd (5 min.)




Live pricePrice per Share (EOD)
¥14.24

2.2. Growth of Guangdong Taienkang Pharmaceutical Co. Ltd (5 min.)




Is Guangdong Taienkang Pharmaceutical Co. Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$246.1m$256.1m-$2.7m-1.1%

How much money is Guangdong Taienkang Pharmaceutical Co. Ltd making?

Current yearPrevious yearGrowGrow %
Making money$4.7m$7.1m-$2.3m-50.6%
Net Profit Margin18.1%25.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Guangdong Taienkang Pharmaceutical Co. Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Guangdong Taienkang Pharmaceutical Co. Ltd?

Welcome investor! Guangdong Taienkang Pharmaceutical Co. Ltd's management wants to use your money to grow the business. In return you get a share of Guangdong Taienkang Pharmaceutical Co. Ltd.

First you should know what it really means to hold a share of Guangdong Taienkang Pharmaceutical Co. Ltd. And how you can make/lose money.

Speculation

The Price per Share of Guangdong Taienkang Pharmaceutical Co. Ltd is ¥14.24. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Guangdong Taienkang Pharmaceutical Co. Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Guangdong Taienkang Pharmaceutical Co. Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥4.19. Based on the TTM, the Book Value Change Per Share is ¥-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.08 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Guangdong Taienkang Pharmaceutical Co. Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.1%0.010.1%0.020.1%0.010.1%0.010.1%
Usd Book Value Change Per Share-0.03-0.2%0.000.0%0.010.0%0.060.4%0.060.4%
Usd Dividend Per Share0.040.3%0.010.1%0.010.1%0.010.1%0.010.1%
Usd Total Gains Per Share0.010.1%0.010.1%0.020.1%0.070.5%0.070.5%
Usd Price Per Share1.73-2.11-4.01-3.35-3.35-
Price to Earnings Ratio33.09-54.89-60.66-67.86-67.86-
Price-to-Total Gains Ratio140.53-35.52-230.41-165.80-165.80-
Price to Book Ratio2.99-3.53-6.64-5.63-5.63-
Price-to-Total Gains Ratio140.53-35.52-230.41-165.80-165.80-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.967968
Number of shares508
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.000.06
Usd Total Gains Per Share0.010.07
Gains per Quarter (508 shares)4.2535.71
Gains per Year (508 shares)16.98142.82
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
124-7725118133
247-132451235276
371-204176353419
495-2758101470562
5118-3375126588705
6142-4092152705848
7166-47109177823991
8189-541262029401134
9213-6014322710581277
10237-6716025311761420

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%
Book Value Change Per Share2.02.00.050.0%6.04.00.060.0%6.04.00.060.0%6.04.00.060.0%6.04.00.060.0%
Dividend per Share4.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%
Total Gains per Share3.01.00.075.0%9.01.00.090.0%9.01.00.090.0%9.01.00.090.0%9.01.00.090.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Guangdong Taienkang Pharmaceutical Co. Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.213-0.024-89%0.038-662%0.419-151%0.419-151%
Book Value Per Share--4.1864.310-3%4.357-4%4.306-3%4.306-3%
Current Ratio--3.4604.764-27%8.386-59%7.031-51%7.031-51%
Debt To Asset Ratio--0.2100.174+21%0.102+106%0.132+59%0.132+59%
Debt To Equity Ratio--0.2710.216+25%0.115+136%0.156+73%0.156+73%
Dividend Per Share--0.3030.084+259%0.091+233%0.090+236%0.090+236%
Eps--0.0950.080+18%0.121-22%0.099-4%0.099-4%
Free Cash Flow Per Share--0.043-0.090+309%0.027+59%-0.023+152%-0.023+152%
Free Cash Flow To Equity Per Share--0.043-0.090+309%0.027+59%-0.023+152%-0.023+152%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap6059091292.160+12%5331489739.5206485653021.120-18%12341579663.370-57%10308969411.332-48%10308969411.332-48%
Net Profit Margin--0.1950.181+8%0.253-23%0.216-9%0.216-9%
Operating Margin----0%-0%-0%-0%
Operating Ratio--1.1641.177-1%1.106+5%1.146+2%1.146+2%
Pb Ratio3.402+12%2.9933.534-15%6.637-55%5.625-47%5.625-47%
Pe Ratio37.605+12%33.08954.887-40%60.660-45%67.861-51%67.861-51%
Price Per Share14.240+12%12.53015.243-18%29.005-57%24.228-48%24.228-48%
Price To Free Cash Flow Ratio82.589+12%72.671-12.254+117%100.072-27%27.548+164%27.548+164%
Price To Total Gains Ratio159.714+12%140.53535.516+296%230.409-39%165.796-15%165.796-15%
Quick Ratio--1.4242.191-35%3.742-62%3.052-53%3.052-53%
Return On Assets--0.0180.015+16%0.025-28%0.020-10%0.020-10%
Return On Equity--0.0230.019+21%0.028-18%0.0230%0.0230%
Total Gains Per Share--0.0890.060+47%0.129-31%0.509-82%0.509-82%
Usd Book Value--246159343.609253419843.374-3%256181891.667-4%253221237.762-3%253221237.762-3%
Usd Book Value Change Per Share---0.029-0.003-89%0.005-662%0.058-151%0.058-151%
Usd Book Value Per Share--0.5790.596-3%0.602-4%0.595-3%0.595-3%
Usd Dividend Per Share--0.0420.012+259%0.013+233%0.012+236%0.012+236%
Usd Eps--0.0130.011+18%0.017-22%0.014-4%0.014-4%
Usd Free Cash Flow--2534748.543-5299779.836+309%1594198.489+59%-1326012.295+152%-1326012.295+152%
Usd Free Cash Flow Per Share--0.006-0.012+309%0.004+59%-0.003+152%-0.003+152%
Usd Free Cash Flow To Equity Per Share--0.006-0.012+309%0.004+59%-0.003+152%-0.003+152%
Usd Market Cap837366416.577+12%736811882.002896317247.519-18%1705606309.478-57%1424699572.646-48%1424699572.646-48%
Usd Price Per Share1.968+12%1.7322.107-18%4.008-57%3.348-48%3.348-48%
Usd Profit--5566852.3194729764.829+18%7121112.741-22%5812189.945-4%5812189.945-4%
Usd Revenue--28513356.66225951321.154+10%28116736.668+1%26806601.690+6%26806601.690+6%
Usd Total Gains Per Share--0.0120.008+47%0.018-31%0.070-82%0.070-82%
 EOD+4 -4MRQTTM+21 -13YOY+12 -225Y+11 -2310Y+11 -23

3.3 Fundamental Score

Let's check the fundamental score of Guangdong Taienkang Pharmaceutical Co. Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1537.605
Price to Book Ratio (EOD)Between0-13.402
Net Profit Margin (MRQ)Greater than00.195
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.424
Current Ratio (MRQ)Greater than13.460
Debt to Asset Ratio (MRQ)Less than10.210
Debt to Equity Ratio (MRQ)Less than10.271
Return on Equity (MRQ)Greater than0.150.023
Return on Assets (MRQ)Greater than0.050.018
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Guangdong Taienkang Pharmaceutical Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.204
Ma 20Greater thanMa 5014.422
Ma 50Greater thanMa 10013.774
Ma 100Greater thanMa 20013.423
OpenGreater thanClose14.250
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Guangdong Taienkang Pharmaceutical Co. Ltd

Guangdong Taienkang Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company provides products covering various therapeutic areas, including gender health medicines, ophthalmic medicines, gastrointestinal medicines, Chinese patent medicines and external medicines, and sanitary materials in the forms of tablets, pills, injections, and essential oils; medical technology and technology transfer services; and medical devices. It also operates as an agent for pharmaceutical products; and offers medical and daily cotton swabs, masks, sutures, surgical staplers, vascular clips and clip appliers, etc., as well as non-prescription drugs. The company was formerly known as Shantou Taikang Pharmaceutical Co., Ltd. and changed its name to Guangdong Taienkang Pharmaceutical Co., Ltd. in June 2006. Guangdong Taienkang Pharmaceutical Co., Ltd. was founded in 1999 and is headquartered in Shantou, China.

Fundamental data was last updated by Penke on 2024-11-12 09:45:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Guangdong Taienkang Pharmaceutical Co. Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Guangdong Taienkang Pharmaceutical Co. Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 19.5% means that ¥0.20 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Guangdong Taienkang Pharmaceutical Co. Ltd:

  • The MRQ is 19.5%. The company is making a huge profit. +2
  • The TTM is 18.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ19.5%TTM18.1%+1.4%
TTM18.1%YOY25.3%-7.2%
TTM18.1%5Y21.6%-3.5%
5Y21.6%10Y21.6%0.0%
4.3.1.2. Return on Assets

Shows how efficient Guangdong Taienkang Pharmaceutical Co. Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Guangdong Taienkang Pharmaceutical Co. Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.8% Return on Assets means that Guangdong Taienkang Pharmaceutical Co. Ltd generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Guangdong Taienkang Pharmaceutical Co. Ltd:

  • The MRQ is 1.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.8%TTM1.5%+0.2%
TTM1.5%YOY2.5%-1.0%
TTM1.5%5Y2.0%-0.5%
5Y2.0%10Y2.0%0.0%
4.3.1.3. Return on Equity

Shows how efficient Guangdong Taienkang Pharmaceutical Co. Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Guangdong Taienkang Pharmaceutical Co. Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.3% Return on Equity means Guangdong Taienkang Pharmaceutical Co. Ltd generated ¥0.02 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Guangdong Taienkang Pharmaceutical Co. Ltd:

  • The MRQ is 2.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.3%TTM1.9%+0.4%
TTM1.9%YOY2.8%-0.9%
TTM1.9%5Y2.3%-0.4%
5Y2.3%10Y2.3%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Guangdong Taienkang Pharmaceutical Co. Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Guangdong Taienkang Pharmaceutical Co. Ltd is operating .

  • Measures how much profit Guangdong Taienkang Pharmaceutical Co. Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Guangdong Taienkang Pharmaceutical Co. Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Guangdong Taienkang Pharmaceutical Co. Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
4.3.2.2. Operating Ratio

Measures how efficient Guangdong Taienkang Pharmaceutical Co. Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.16 means that the operating costs are ¥1.16 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Guangdong Taienkang Pharmaceutical Co. Ltd:

  • The MRQ is 1.164. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.177. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.164TTM1.177-0.012
TTM1.177YOY1.106+0.070
TTM1.1775Y1.146+0.030
5Y1.14610Y1.1460.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Guangdong Taienkang Pharmaceutical Co. Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Guangdong Taienkang Pharmaceutical Co. Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.46 means the company has ¥3.46 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Guangdong Taienkang Pharmaceutical Co. Ltd:

  • The MRQ is 3.460. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.764. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.460TTM4.764-1.304
TTM4.764YOY8.386-3.622
TTM4.7645Y7.031-2.267
5Y7.03110Y7.0310.000
4.4.3.2. Quick Ratio

Measures if Guangdong Taienkang Pharmaceutical Co. Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Guangdong Taienkang Pharmaceutical Co. Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.42 means the company can pay off ¥1.42 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Guangdong Taienkang Pharmaceutical Co. Ltd:

  • The MRQ is 1.424. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 2.191. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.424TTM2.191-0.767
TTM2.191YOY3.742-1.551
TTM2.1915Y3.052-0.861
5Y3.05210Y3.0520.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Guangdong Taienkang Pharmaceutical Co. Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Guangdong Taienkang Pharmaceutical Co. Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Guangdong Taienkang Pharmaceutical Co. Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.21 means that Guangdong Taienkang Pharmaceutical Co. Ltd assets are financed with 21.0% credit (debt) and the remaining percentage (100% - 21.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Guangdong Taienkang Pharmaceutical Co. Ltd:

  • The MRQ is 0.210. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.174. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.210TTM0.174+0.036
TTM0.174YOY0.102+0.072
TTM0.1745Y0.132+0.042
5Y0.13210Y0.1320.000
4.5.4.2. Debt to Equity Ratio

Measures if Guangdong Taienkang Pharmaceutical Co. Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Guangdong Taienkang Pharmaceutical Co. Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 27.1% means that company has ¥0.27 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Guangdong Taienkang Pharmaceutical Co. Ltd:

  • The MRQ is 0.271. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.216. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.271TTM0.216+0.055
TTM0.216YOY0.115+0.101
TTM0.2165Y0.156+0.059
5Y0.15610Y0.1560.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Guangdong Taienkang Pharmaceutical Co. Ltd generates.

  • Above 15 is considered overpriced but always compare Guangdong Taienkang Pharmaceutical Co. Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 33.09 means the investor is paying ¥33.09 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Guangdong Taienkang Pharmaceutical Co. Ltd:

  • The EOD is 37.605. Based on the earnings, the company is overpriced. -1
  • The MRQ is 33.089. Based on the earnings, the company is overpriced. -1
  • The TTM is 54.887. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD37.605MRQ33.089+4.516
MRQ33.089TTM54.887-21.797
TTM54.887YOY60.660-5.773
TTM54.8875Y67.861-12.974
5Y67.86110Y67.8610.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Guangdong Taienkang Pharmaceutical Co. Ltd:

  • The EOD is 82.589. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 72.671. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is -12.254. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD82.589MRQ72.671+9.918
MRQ72.671TTM-12.254+84.925
TTM-12.254YOY100.072-112.327
TTM-12.2545Y27.548-39.802
5Y27.54810Y27.5480.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Guangdong Taienkang Pharmaceutical Co. Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Guangdong Taienkang Pharmaceutical Co. Ltd:

  • The EOD is 3.402. Based on the equity, the company is fair priced.
  • The MRQ is 2.993. Based on the equity, the company is underpriced. +1
  • The TTM is 3.534. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.402MRQ2.993+0.408
MRQ2.993TTM3.534-0.540
TTM3.534YOY6.637-3.103
TTM3.5345Y5.625-2.092
5Y5.62510Y5.6250.000
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,254,485
Total Liabilities473,303
Total Stockholder Equity1,748,788
 As reported
Total Liabilities 473,303
Total Stockholder Equity+ 1,748,788
Total Assets = 2,254,485

Assets

Total Assets2,254,485
Total Current Assets1,178,096
Long-term Assets1,076,389
Total Current Assets
Cash And Cash Equivalents 501,518
Short-term Investments 140,300
Net Receivables 344,642
Inventory 100,005
Other Current Assets 22,702
Total Current Assets  (as reported)1,178,096
Total Current Assets  (calculated)1,109,167
+/- 68,929
Long-term Assets
Property Plant Equipment 509,008
Goodwill 200,644
Intangible Assets 279,425
Long-term Assets Other 22,738
Long-term Assets  (as reported)1,076,389
Long-term Assets  (calculated)1,011,815
+/- 64,574

Liabilities & Shareholders' Equity

Total Current Liabilities340,451
Long-term Liabilities132,852
Total Stockholder Equity1,748,788
Total Current Liabilities
Short Long Term Debt 165,729
Accounts payable 101,514
Other Current Liabilities 407
Total Current Liabilities  (as reported)340,451
Total Current Liabilities  (calculated)267,650
+/- 72,801
Long-term Liabilities
Long term Debt 96,000
Capital Lease Obligations Min Short Term Debt1,436
Long-term Liabilities  (as reported)132,852
Long-term Liabilities  (calculated)97,436
+/- 35,416
Total Stockholder Equity
Retained Earnings 376,918
Total Stockholder Equity (as reported)1,748,788
Total Stockholder Equity (calculated)376,918
+/- 1,371,870
Other
Capital Stock425,498
Common Stock Shares Outstanding 425,498
Net Invested Capital 2,010,517
Net Working Capital 837,646
Property Plant and Equipment Gross 509,008



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-31
> Total Assets 
2,072,059
1,935,589
1,985,621
2,038,805
2,182,265
2,052,427
2,111,528
2,229,112
2,290,179
2,254,485
2,254,4852,290,1792,229,1122,111,5282,052,4272,182,2652,038,8051,985,6211,935,5892,072,059
   > Total Current Assets 
1,675,416
1,536,791
1,519,585
1,533,074
1,426,255
1,268,254
1,263,119
1,187,293
1,225,745
1,178,096
1,178,0961,225,7451,187,2931,263,1191,268,2541,426,2551,533,0741,519,5851,536,7911,675,416
       Cash And Cash Equivalents 
1,230,640
442,473
425,819
806,786
553,120
538,584
496,161
455,643
422,924
501,518
501,518422,924455,643496,161538,584553,120806,786425,819442,4731,230,640
       Short-term Investments 
0
626,259
603,584
240,649
376,262
221,608
273,127
251,803
252,876
140,300
140,300252,876251,803273,127221,608376,262240,649603,584626,2590
       Net Receivables 
220,629
241,488
253,720
269,089
294,395
298,540
314,530
311,575
328,761
344,642
344,642328,761311,575314,530298,540294,395269,089253,720241,488220,629
       Inventory 
86,266
77,060
85,742
80,523
93,158
86,446
94,352
86,549
101,396
100,005
100,005101,39686,54994,35286,44693,15880,52385,74277,06086,266
       Other Current Assets 
157
8,618
13,204
5,916
8,007
9,677
10,821
18,471
20,115
22,702
22,70220,11518,47110,8219,6778,0075,91613,2048,618157
   > Long-term Assets 
396,643
398,799
466,036
505,731
756,010
784,173
848,408
1,041,819
1,064,433
1,076,389
1,076,3891,064,4331,041,819848,408784,173756,010505,731466,036398,799396,643
       Property Plant Equipment 
0
0
0
0
320,355
334,893
364,106
483,740
495,974
509,008
509,008495,974483,740364,106334,893320,3550000
       Goodwill 
27,327
27,327
27,327
27,327
200,644
200,644
200,644
200,644
200,644
200,644
200,644200,644200,644200,644200,644200,64427,32727,32727,32727,327
       Intangible Assets 
69,580
80,756
82,441
91,741
159,939
159,744
165,115
276,455
278,392
279,425
279,425278,392276,455165,115159,744159,93991,74182,44180,75669,580
       Long-term Assets Other 
15,342
4,276
13,251
5,492
12,638
28,689
60,394
14,019
24,139
22,738
22,73824,13914,01960,39428,68912,6385,49213,2514,27615,342
> Total Liabilities 
256,060
178,466
178,729
184,844
250,025
230,705
259,212
399,717
418,198
473,303
473,303418,198399,717259,212230,705250,025184,844178,729178,466256,060
   > Total Current Liabilities 
225,557
149,486
150,290
156,325
206,214
188,985
191,678
253,129
283,975
340,451
340,451283,975253,129191,678188,985206,214156,325150,290149,486225,557
       Short Long Term Debt 
97,566
51,583
31,036
20,024
20,010
21,660
37,165
53,836
89,319
165,729
165,72989,31953,83637,16521,66020,01020,02431,03651,58397,566
       Accounts payable 
51,534
43,393
49,786
56,595
58,605
52,558
49,711
121,186
113,800
101,514
101,514113,800121,18649,71152,55858,60556,59549,78643,39351,534
       Other Current Liabilities 
243
519
536
659
412
442
376
483
459
407
407459483376442412659536519243
   > Long-term Liabilities 
30,503
28,980
28,438
28,518
43,810
41,720
67,534
146,589
134,224
132,852
132,852134,224146,58967,53441,72043,81028,51828,43828,98030,503
       Capital Lease Obligations Min Short Term Debt
713
0
0
1,961
1,653
1,285
1,085
1,119
962
1,436
1,4369621,1191,0851,2851,6531,96100713
> Total Stockholder Equity
1,816,146
1,757,268
1,807,036
1,854,118
1,906,011
1,797,071
1,830,244
1,789,983
1,835,564
1,748,788
1,748,7881,835,5641,789,9831,830,2441,797,0711,906,0111,854,1181,807,0361,757,2681,816,146
   Common Stock0000000000
   Retained Earnings 
428,342
369,288
418,890
440,175
492,161
383,757
416,525
418,223
463,691
376,918
376,918463,691418,223416,525383,757492,161440,175418,890369,288428,342
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 0000000000



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue760,787
Cost of Revenue-299,724
Gross Profit461,063461,063
 
Operating Income (+$)
Gross Profit461,063
Operating Expense-569,936
Operating Income190,851-108,873
 
Operating Expense (+$)
Research Development62,886
Selling General Administrative160,950
Selling And Marketing Expenses0
Operating Expense569,936223,836
 
Net Interest Income (+$)
Interest Income8,782
Interest Expense-1,701
Other Finance Cost-107
Net Interest Income6,974
 
Pretax Income (+$)
Operating Income190,851
Net Interest Income6,974
Other Non-Operating Income Expenses0
Income Before Tax (EBT)192,325190,851
EBIT - interestExpense = -1,701
160,200
161,902
Interest Expense1,701
Earnings Before Interest and Taxes (EBIT)0194,026
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax192,325
Tax Provision-38,824
Net Income From Continuing Ops153,500153,500
Net Income160,200
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-6,974
 

Technical Analysis of Guangdong Taienkang Pharmaceutical Co. Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Guangdong Taienkang Pharmaceutical Co. Ltd. The general trend of Guangdong Taienkang Pharmaceutical Co. Ltd is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Guangdong Taienkang Pharmaceutical Co. Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Guangdong Taienkang Pharmaceutical Co. Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 15.66 < 16.71 < 16.84.

The bearish price targets are: 13.52 > 13.45 > 13.28.

Tweet this
Guangdong Taienkang Pharmaceutical Co. Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Guangdong Taienkang Pharmaceutical Co. Ltd. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Guangdong Taienkang Pharmaceutical Co. Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Guangdong Taienkang Pharmaceutical Co. Ltd. The current macd is 0.10621207.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Guangdong Taienkang Pharmaceutical Co. Ltd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Guangdong Taienkang Pharmaceutical Co. Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Guangdong Taienkang Pharmaceutical Co. Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Guangdong Taienkang Pharmaceutical Co. Ltd Daily Moving Average Convergence/Divergence (MACD) ChartGuangdong Taienkang Pharmaceutical Co. Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Guangdong Taienkang Pharmaceutical Co. Ltd. The current adx is 31.06.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Guangdong Taienkang Pharmaceutical Co. Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Guangdong Taienkang Pharmaceutical Co. Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Guangdong Taienkang Pharmaceutical Co. Ltd. The current sar is 15.41.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Guangdong Taienkang Pharmaceutical Co. Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Guangdong Taienkang Pharmaceutical Co. Ltd. The current rsi is 50.20. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Guangdong Taienkang Pharmaceutical Co. Ltd Daily Relative Strength Index (RSI) ChartGuangdong Taienkang Pharmaceutical Co. Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Guangdong Taienkang Pharmaceutical Co. Ltd. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Guangdong Taienkang Pharmaceutical Co. Ltd price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Guangdong Taienkang Pharmaceutical Co. Ltd Daily Stochastic Oscillator ChartGuangdong Taienkang Pharmaceutical Co. Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Guangdong Taienkang Pharmaceutical Co. Ltd. The current cci is -34.16140351.

Guangdong Taienkang Pharmaceutical Co. Ltd Daily Commodity Channel Index (CCI) ChartGuangdong Taienkang Pharmaceutical Co. Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Guangdong Taienkang Pharmaceutical Co. Ltd. The current cmo is -4.44024152.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Guangdong Taienkang Pharmaceutical Co. Ltd Daily Chande Momentum Oscillator (CMO) ChartGuangdong Taienkang Pharmaceutical Co. Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Guangdong Taienkang Pharmaceutical Co. Ltd. The current willr is -72.82051282.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Guangdong Taienkang Pharmaceutical Co. Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Guangdong Taienkang Pharmaceutical Co. Ltd Daily Williams %R ChartGuangdong Taienkang Pharmaceutical Co. Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Guangdong Taienkang Pharmaceutical Co. Ltd.

Guangdong Taienkang Pharmaceutical Co. Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Guangdong Taienkang Pharmaceutical Co. Ltd. The current atr is 0.52776633.

Guangdong Taienkang Pharmaceutical Co. Ltd Daily Average True Range (ATR) ChartGuangdong Taienkang Pharmaceutical Co. Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Guangdong Taienkang Pharmaceutical Co. Ltd. The current obv is 286,999,945.

Guangdong Taienkang Pharmaceutical Co. Ltd Daily On-Balance Volume (OBV) ChartGuangdong Taienkang Pharmaceutical Co. Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Guangdong Taienkang Pharmaceutical Co. Ltd. The current mfi is 62.98.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Guangdong Taienkang Pharmaceutical Co. Ltd Daily Money Flow Index (MFI) ChartGuangdong Taienkang Pharmaceutical Co. Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Guangdong Taienkang Pharmaceutical Co. Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-25MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-31CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-09MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-30MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-10MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Guangdong Taienkang Pharmaceutical Co. Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Guangdong Taienkang Pharmaceutical Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.204
Ma 20Greater thanMa 5014.422
Ma 50Greater thanMa 10013.774
Ma 100Greater thanMa 20013.423
OpenGreater thanClose14.250
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Guangdong Taienkang Pharmaceutical Co. Ltd with someone you think should read this too:
  • Are you bullish or bearish on Guangdong Taienkang Pharmaceutical Co. Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Guangdong Taienkang Pharmaceutical Co. Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Guangdong Taienkang Pharmaceutical Co. Ltd

I send you an email if I find something interesting about Guangdong Taienkang Pharmaceutical Co. Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Guangdong Taienkang Pharmaceutical Co. Ltd.

Receive notifications about Guangdong Taienkang Pharmaceutical Co. Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.